Biotech Stocks Rally on Positive Clinical Data and Earnings Updates

miércoles, 7 de enero de 2026, 10:19 pm ET1 min de lectura
ACRV--
ALXO--
GMED--

Several biotech and healthcare companies posted notable gains in after-hours trading, driven by clinical updates, financial results, and upcoming industry presentations. ALX Oncology Holdings surged 10.17% after announcing positive data from a Phase 2 trial of its lead candidate. Globus Medical climbed 9.34% after releasing preliminary unaudited sales results, with full-year 2025 sales expected to reach $2.936 billion. Acrivon Therapeutics rose 6.44% after announcing plans to release clinical data updates.

Biotech Stocks Rally on Positive Clinical Data and Earnings Updates

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios